Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
The SH2 Domain Regulates c-Abl Kinase Activation by a Cyclin-Like Mechanism and Remodulation of the Hinge Motion | PLOS Computational Biology
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase: Cell
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction | Encyclopedia MDPI
BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram
Frontiers | c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
The role of non-receptor tyrosine kinases c-Abl and c-Src | Yosef Shaul's Lab
Opening the door to the development of novel Abl kinase inhibitors | Future Medicinal Chemistry
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
![PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7afde5a58c37047c83cde7051c4024ff35912884/2-Figure1-1.png "PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar")
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
Conformational states dynamically populated by a kinase determine its function | Science
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
JCI - Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review. | Semantic Scholar
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors | PNAS
Proposed mechanisms for the regulation of c-Abl tyrosine kinase. The... | Download Scientific Diagram
